Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells.

Bruyer A, Maes K, Herviou L, Kassambara A, Seckinger A, Cartron G, Rème T, Robert N, Requirand G, Boireau S, Müller-Tidow C, Veyrune JL, Vincent L, Bouhya S, Goldschmidt H, Vanderkerken K, Hose D, Klein B, De Bruyne E, Moreaux J.

Br J Cancer. 2018 Apr;118(8):1062-1073. doi: 10.1038/s41416-018-0025-x. Epub 2018 Mar 2.

2.

Teaching removable partial denture design: 'METACIEL', a novel digital procedure.

Bonnet G, Lance C, Bessadet M, Tamini F, Veyrune JL, Francois O, Nicolas E.

Int J Med Educ. 2018 Jan 26;9:24-25. doi: 10.5116/ijme.5a5b.2b0d. No abstract available.

3.

A new digital denture procedure: a first practitioners appraisal.

Bonnet G, Batisse C, Bessadet M, Nicolas E, Veyrune JL.

BMC Oral Health. 2017 Dec 20;17(1):155. doi: 10.1186/s12903-017-0440-z.

4.

Predictive Parameters of Oral Health Quality of Life in Complete Mandibular Denture Wearers Stabilized by Mini-Implants: A Two-Year Follow-Up Study.

Batisse C, Bonnet G, Veyrune JL, Nicolas E, Bessadet M.

Materials (Basel). 2017 Oct 19;10(10). pii: E1197. doi: 10.3390/ma10101197.

5.

Influence of the renewal of removable dentures on oral health related quality of life.

Bonnet G, Batisse C, Segyo JW, Veyrune JL, Nicolas E, Bessadet M.

Springerplus. 2016 Nov 28;5(1):2019. eCollection 2016.

6.

Ceramo-Metal Crown or Cad-Cam Rehabilitation: Patient and Practitioner Appraisal.

Batisse C, Bessadet M, Decerle N, Veyrune JL, Nicolas E.

Eur J Prosthodont Restor Dent. 2014 Dec;22(4):159-65.

PMID:
26466440
7.

DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidine.

Moreaux J, Bruyer A, Veyrune JL, Goldschmidt H, Hose D, Klein B.

Br J Haematol. 2014 Feb;164(4):613-6. doi: 10.1111/bjh.12660. Epub 2013 Nov 13. No abstract available.

8.

Impact of removable partial denture prosthesis on chewing efficiency.

Bessadet M, Nicolas E, Sochat M, Hennequin M, Veyrune JL.

J Appl Oral Sci. 2013 Sep-Oct;21(5):392-6. doi: 10.1590/1679-775720130046.

9.

Geriatric slim implants for complete denture wearers: clinical aspects and perspectives.

Huard C, Bessadet M, Nicolas E, Veyrune JL.

Clin Cosmet Investig Dent. 2013 Aug 28;5:63-8. doi: 10.2147/CCIDE.S47743. eCollection 2013.

10.

Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cells.

Kassambara A, Schoenhals M, Moreaux J, Veyrune JL, Rème T, Goldschmidt H, Hose D, Klein B.

PLoS One. 2013 Apr 30;8(4):e62752. doi: 10.1371/journal.pone.0062752. Print 2013.

11.

Krüppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myeloma.

Schoenhals M, Kassambara A, Veyrune JL, Moreaux J, Goldschmidt H, Hose D, Klein B.

Haematologica. 2013 Sep;98(9):1442-9. doi: 10.3324/haematol.2012.066944. Epub 2013 Apr 12.

12.

Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?

Caraux A, Vincent L, Bouhya S, Quittet P, Moreaux J, Requirand G, Veyrune JL, Olivier G, Cartron G, Rossi JF, Klein B.

Oncotarget. 2012 Nov;3(11):1335-47.

13.

Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitors.

Moreaux J, Rème T, Leonard W, Veyrune JL, Requirand G, Goldschmidt H, Hose D, Klein B.

Mol Cancer Ther. 2012 Dec;11(12):2685-92. doi: 10.1158/1535-7163.MCT-12-0721. Epub 2012 Oct 18.

14.

Nutritional status, dietary intake and oral quality of life in elderly complete denture wearers.

Cousson PY, Bessadet M, Nicolas E, Veyrune JL, Lesourd B, Lassauzay C.

Gerodontology. 2012 Jun;29(2):e685-92. doi: 10.1111/j.1741-2358.2011.00545.x. Epub 2011 Oct 17.

PMID:
22004061
15.

Effect of dental status on changes in mastication in patients with obesity following bariatric surgery.

Godlewski AE, Veyrune JL, Nicolas E, Ciangura CA, Chaussain CC, Czernichow S, Basdevant A, Hennequin M.

PLoS One. 2011;6(7):e22324. doi: 10.1371/journal.pone.0022324. Epub 2011 Jul 20.

16.

A six-month assessment of oral health-related quality of life of complete denture wearers using denture adhesive: a pilot study.

Nicolas E, Veyrune JL, Lassauzay C.

J Prosthodont. 2010 Aug;19(6):443-8. doi: 10.1111/j.1532-849X.2010.00601.x. Epub 2010 Apr 29.

PMID:
20456031
17.

Increased plasma-immune cytokines throughout the high-dose melphalan-induced lymphodepletion in patients with multiple myeloma: a window for adoptive immunotherapy.

Condomines M, Veyrune JL, Larroque M, Quittet P, Latry P, Lugagne C, Hertogh C, Kanouni T, Rossi JF, Klein B.

J Immunol. 2010 Jan 15;184(2):1079-84. doi: 10.4049/jimmunol.0804159. Epub 2009 Dec 4.

18.

APRIL is overexpressed in cancer: link with tumor progression.

Moreaux J, Veyrune JL, De Vos J, Klein B.

BMC Cancer. 2009 Mar 16;9:83. doi: 10.1186/1471-2407-9-83.

19.

CD200: a putative therapeutic target in cancer.

Moreaux J, Veyrune JL, Reme T, De Vos J, Klein B.

Biochem Biophys Res Commun. 2008 Feb 1;366(1):117-22. Epub 2007 Dec 4.

PMID:
18060862
20.

Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.

Jourdan M, Mahtouk K, Veyrune JL, Couderc G, Fiol G, Redal N, Duperray C, De Vos J, Klein B.

Eur Cytokine Netw. 2005 Jan-Mar;16(1):57-64.

Supplemental Content

Loading ...
Support Center